Sentences with phrase «tumor recurrence after»

Slow down lymphoma growth modestly and show no effect on tumor regression; delay tumor recurrence with activation of p53; enhance tumor regression and inhibit tumor recurrence after alkylating drug therapy.
tumors from neural stem cells also contained more glioblastoma stem cells, cells that are believed to give rise to tumor recurrence after therapy,» says Lene Uhrbom, senior lecturer at the Department of Immunology, Genetics and Pathology and lead author of the study.
Cancer stem cells, a type of self - renewing cell found in tumors, are of particular interest because they are the main cell type responsible for tumor progression and for resistance to chemotherapy and radiotherapy, and therefore a major cause of tumor recurrence after treatment.
«In order to block tumor recurrence after radiation therapy, we used an antibody to target and inhibit these cancer stem cells,» said Dr. Xu.

Not exact matches

After adjusting for age, tumor location, and stage, researchers from Cleveland Clinic's Dermatology & Plastic Surgery Institute discovered that women diagnosed with malignant melanoma during their pregnancy or within one year of giving birth were 5.1 - times as likely to die, 6.9 - times as likely to experience metastasis, and 9.2 - times more likely to have a recurrence.
Liang Xu, Ph.D. member of the KU Cancer Center's Drug Discovery, Delivery and Experimental Therapeutics program and associate professor of molecular biosciences at KU, has discovered that targeting a cell - surface receptor called «CD44s» can block pancreatic tumor formation and recurrence after radiotherapy.
Cancer can become deadly after surgery to remove a primary tumor because of the possibility of recurrence of the cancer at the surgery site and other parts of the body.
Of the 82 treated patients with small tumors, 96 percent (79 of 82) have had no recurrence more than three years after treatment, and 80 percent (28 of 35) of those with mid-size tumors also have had no recurrence.
A new study by UCLA scientists has found that women diagnosed with breast cancer and treated with a one - week regimen of partial breast radiation after the surgical removal of the tumor, or lumpectomy, saw no increase in cancer recurrence or difference in cosmetic outcomes compared to women who received radiation of the entire breast for a period of up to six weeks after surgery.
Nine additional patients had recurrence within the involved lobe (range, 0.1 to 5.9 years after SBRT), resulting in a five - year primary tumor and involved lobe (local) failure rate of 20 percent.
Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell - based hyperthermic tumor vaccine.
There was also variation based on histology, with the highest rate of local recurrence at about a year after surgery seen in malignant peripheral nerve sheath tumors (MPNST), followed by myxofibrosarcoma; both those types saw persistently elevated rates compared to other subtypes out beyond 5 years.
DENVER — Three manuscripts published in the recent issue of the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (IASLC), explored the versatility of liquid biopsies by identifying EGFR mutations using circulating tumor DNA (ctDNA) in urine and plasma and examining circulating tumor cells (CTCs) in plasma to predict the risk of lung cancer recurrence after surgical resection.
Consequently, most patients with advanced disease have died from a local recurrence of their tumor, even after aggressive treatment.
Researchers continue to find novel ways to explore these biomarkers using ddPCR technology, whether they are epigenetic markers to determine cancer recurrence after surgery or cell - free DNA (cfDNA) derived from a tumor that reveals the effectiveness of immunotherapy.
Almost all brain and pituitary tumor patients undergo repeated MRI scans after treatment to observe for the possible recurrence of their tumors.
Radiation Therapy Prolongs Life in Men with Recurrent Prostate Cancer Men whose tumors recur after prostate cancer surgery are three times more likely to survive their disease long term if they undergo radiotherapy within two years of the recurrence.
Positron emission tomography (PET) imaging of metabolic tumor burden at diagnosis and after induction therapy can help identify patients most at risk of follicular lymphoma (FL) recurrence, but more work is needed to differentiate high - risk and moderate - risk patients, suggested findings from a pooled analysis of data from three prospective clinical trials, published in Blood.
Even with aggressive surgery, the tumor recurrence rate is very high (at least 50 % by 6 months after surgery).
Dogs that are tumor - free after 6 months are considered unlikely to have a recurrence.
The complications that might arise after limb - sparing surgery could be implant failure, local tumor recurrence, and infection.
If the mammary tumor is malignant, the surgical site and regional lymph nodes should be checked for local tumor recurrence and metastasis, respectively, every 3 months for the first 12 months after surgery and then every 6 months thereafter.
For dogs with large breast tumors (> 3.0 cm), the prognosis tends to be poor since there is an 80 % chance of recurrence of the tumor within 6 months after canine breast cancer treatment.
a b c d e f g h i j k l m n o p q r s t u v w x y z